Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 4 1

Status

Terminated 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 3

Conditions

Carcinoma, Non-Small-Cell Lung 330Breast Neoplasms 185Lung Neoplasms 177Ovarian Neoplasms 156Triple Negative Breast Neoplasms 88Fallopian Tube Neoplasms 75Squamous Cell Carcinoma of Head and Neck 74Small Cell Lung Carcinoma 67Esophageal Neoplasms 55Neoplasms 49Head and Neck Neoplasms 47Carcinoma, Ovarian Epithelial 44Uterine Cervical Neoplasms 36Esophageal Squamous Cell Carcinoma 36Endometrial Neoplasms 35Prostatic Neoplasms 33Neoplasm Metastasis 32Lymphoma, Large B-Cell, Diffuse 32Recurrence 31Adenocarcinoma of Lung 31Lymphoma 30Brain Neoplasms 29Neuroblastoma 24Central Nervous System Neoplasms 24Retinoblastoma 23Lymphoma, Non-Hodgkin 23Carcinoma, Squamous Cell 23Hodgkin Disease 20Testicular Neoplasms 19Urinary Bladder Neoplasms 16

Interventions

Pemetrexed 4pembrolizumab 3Carboplatin 3Vinorelbine 2Gemcitabine 2vistusertib 1vandetanib 1spartalizumab 1sotorasib 1sintilimab 1olaparib 1icotinib 1durvalumab 1dacomitinib 1capivasertib 1aumolertinib 1Radiosurgery 1Platinum 1MLN 8237 1Injections 1Immune Checkpoint Inhibitors 1Gefitinib 1GC Temporary Stopping 1Erlotinib Hydrochloride 1Drug Therapy 1Cisplatin 1Bevacizumab 1AZD4547 1AZD 8931 1AZD 6244 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Non-small Cell Lung Cancer Metastatic × Carboplatin × Clear all
NCT04836728 2025-03-13

CCICC-002b

Tianjin Medical University Cancer Institute and Hospital

Phase 2 Active not recruiting
156 enrolled
Thoracic

Non-small Cell Lung Cancer Metastatic

NCT06045767 2024-06-03

T-Cell Repertoire Sequencing: Assessing Pembrolizumab Efficacy in Advanced Non-small Lung Cancer

Tel Aviv Medical Center

Phase 2 Not yet recruiting
30 enrolled
Thoracic

Non-small Cell Lung Cancer Metastatic

NCT02299765 2017-11-27

Intercalating and Maintenance Gefitinib in Combination With Chemotherapy for Advanced EGFR-mutant NSCLC

Sichuan University

Phase 4 Terminated
61 enrolled
Thoracic

Non-small Cell Lung Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡